How many insider declarations does 诚达药业 have?

诚达药业 has filed 1 insider declaration with AMF.

Who is the top reporting insider at 诚达药业?

The top reporting insider at 诚达药业 is 陈小红, based on the count of public filings.

What is the net insider buy vs sell volume on 诚达药业?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

诚

诚达药业: management transactions · France · AMF

SZSE:301201FR·AMFMcap 6.3Bn€

AMF ↗

Browse the full directors' dealings record of 诚达药业, a listed issuer based in France. Shares trade on FR FR, under the supervision of AMF. Market capitalisation: €6.3bn. The latest transaction was disclosed on 21 January 2022 — Sale. Among the most active insiders: 陈小红. Every trade is accessible without an account.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

1 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

38.71 €

Income statement

Revenue406.4 M€

Gross profit179.5 M€44% margin

Net income−11.9 M€-2.9% margin

Balance sheet & cash

Market cap6.30 Bn€

Total debt59.1 M€

Free Cash Flow−35.0 M€

Last declaration on 21 January 2022

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations